作为潜在的抗瘤剂的蒂莫金-原黄杂交分子
Sara H H Ahmed1, Bizhar A Tayeb2, Tímea Gonda1
1Institute of Pharmacognosy, University of Szeged, Szeged, Hungary.
PloS one
|January 25, 2024
概括
新的混合化合物,结合了thymoquinone和protoflavone显示强大的抗癌活性. 化合物14对质母细胞瘤和乳腺癌细胞特别有效,显示出显著的瘤选择性.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 蒂莫金和原黄是具有已知的生物活性的天然产品.
- 混合化合物可以提供协同作用或新的治疗效果.
- 开发新的抗癌药物仍然是一个关键的研究领域.
研究的目的:
- 为了合成来自基和原黄的新型配混合化合物.
- 为了评估这些杂交体的体外抗癌活动与各种癌症细胞系对抗.
- 评估最强大的混合动力的选择性和作用机制.
主要方法:
- 合成了八种新型的硫基-原黄以结合的杂交物.
- 在体外细胞毒性测定使用多个人类癌细胞系 (例如乳腺癌,质母细胞瘤) 和正常纤维细胞质.
- 混合化合物的比较活性分析与它们的单个碎片.
主要成果:
- 化合物14在所有测试的细胞系中表现出有希望的广泛抗癌活性.
- 化合物14对MDA-MB-231 (乳腺癌) 和U-87 (质母细胞瘤) 细胞表现出优异的活性.
- 尽管水解很快,但与其碎片的混合物相比,化合物14显示出显著增强的细胞毒性和瘤选择性.
结论:
- 原黄素-基混合物代表了一类有前途的新型抗癌药物.
- 化合物14显示出作为抗瘤剂的显著潜力,特别是在质母细胞瘤.
- 观察到的增强活动和选择性表明混合结构的独特贡献超出了其组件的添加效应.
更多相关视频
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.4K
03:29Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
Published on: May 31, 2024
471
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
